{
  "ticker": "HRMY",
  "company_name": "Harmony Biosciences Holdings, I",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03433131",
      "title": "Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT07051252",
      "title": "A Study of HBS-201 (Pitolisant Delayed-release)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Narcolepsy",
      "start_date": "2025-05-21",
      "completion_date": "2025-10-13",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT05536011",
      "title": "WAKIX\u00ae (Pitolisant) Pregnancy Registry",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Pregnancy Related, Narcolepsy",
      "start_date": "2021-08-24",
      "completion_date": "2030-06-30",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT07219485",
      "title": "A Study of Pitolisant in Participants With Prader-Willi Syndrome",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2025-08-20",
      "completion_date": "2030-08",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT05156047",
      "title": "A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Idiopathic Hypersomnia",
      "start_date": "2022-05-25",
      "completion_date": "2023-09-08",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT06930872",
      "title": "Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Drug Interaction",
      "start_date": "2025-06-06",
      "completion_date": "2025-11",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT04257929",
      "title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2020-12-09",
      "completion_date": "2028-09-07",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT04886518",
      "title": "Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Myotonic Dystrophy 1, Excessive Daytime Sleepiness",
      "start_date": "2021-06-28",
      "completion_date": "2024-10-31",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT06366464",
      "title": "A Study of Pitolisant in Patients With Prader-Willi Syndrome",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2024-05-28",
      "completion_date": "2027-07",
      "enrollment": 0,
      "sponsor": "Harmony Biosciences Management, Inc."
    },
    {
      "nct_id": "NCT05581576",
      "title": "Pitolisant in Refractory Restless Legs Syndrome",
      "status": "UNKNOWN",
      "phase": "PHASE4",
      "condition": "Restless Legs Syndrome",
      "start_date": "2022-09-20",
      "completion_date": "2023-05-01",
      "enrollment": 0,
      "sponsor": "William Ondo, MD"
    }
  ],
  "summary": {
    "total_trials": 26,
    "by_phase": {
      "": 3,
      "PHASE1": 3,
      "PHASE3": 6,
      "PHASE2": 4,
      "PHASE4": 1,
      "NA": 9
    },
    "by_status": {
      "NO_LONGER_AVAILABLE": 1,
      "COMPLETED": 11,
      "RECRUITING": 6,
      "ENROLLING_BY_INVITATION": 1,
      "ACTIVE_NOT_RECRUITING": 4,
      "UNKNOWN": 1,
      "NOT_YET_RECRUITING": 2
    },
    "active_trials": 11,
    "completed_trials": 11,
    "conditions": [
      "Child Abuse, Parental Burnout",
      "Dementia, Mild Cognitive Impairment",
      "Dementia, Nursing Homes Residents",
      "Dravet Syndrome",
      "Drug Interaction",
      "Hair Thinning",
      "Healthy",
      "Healthy, Well-Being, Psychological",
      "Idiopathic Hypersomnia",
      "Idiopathic Hypersomnia, Excessive Daytime Sleepiness",
      "Influenza",
      "Lassa Virus Infection",
      "Lennox Gastaut Syndrome",
      "Myotonic Dystrophy 1, Excessive Daytime Sleepiness",
      "Narcolepsy",
      "Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy",
      "Normal, Sensitive Skin",
      "Palliative Care",
      "Parkinson Disease",
      "Prader-Willi Syndrome",
      "Pregnancy Related, Narcolepsy",
      "Restless Legs Syndrome",
      "Vaccine-Preventable Diseases, Influenza"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:49.298007",
    "search_query": "Harmony Biosciences Holdings, I",
    "url": "https://clinicaltrials.gov/search?term=Harmony+Biosciences+Holdings,+I"
  }
}